self pay glp 1 Teladoc Health, Eli Lilly Partner to Add GLP-1 Self-Pay Option The GLP-1 dilemma: how employers

In the U.S., Medicare price setting begins January 1, 2028, and the compound patent expires Dec 2028, making KEYTRUDAs loss of exclusivity arguably the largest single LOE by revenue on the near-term horizon

At the cellular level, GLP-1RAs influence synaptic plasticity and neuronal excitability, potentially reshaping maladaptive neuroadaptations that underlie craving and relapse

This study suggests breast cancer prevention may be one of the most important questions to answer next.

Fatigue: Some patients report feeling tired as their metabolism shifts

p=0.0044)

Volker Spitzer, Sarah Rickwood, and Matt Stewart discuss how structured nutrition support can bridge the gap between clinical efficacy and real-world outcomes and why collaboration across pharma, nutrition, and digital health is key to long-term success